Pfizer - C4201002 - PF-07265807
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Pfizer, Inc.
Start Date
October 6, 2020
End Date
October 14, 2025
Administered By
Duke Cancer Institute
Awarded By
Pfizer, Inc.
Start Date
October 6, 2020
End Date
October 14, 2025